Elevated miR-9 expression in obese PCOS patients before metformin treatment reflected a heightened pro-inflammatory state, potentially through the NF-κB pathway activation and inflammasome signaling involving IL-1β [35–37]. Here, NFKB1 is linked to polycystic ovary syndrome.